The genus Rhodocodon (Hyacinthaceae sensu APG II) is endemic to Madagascar and its phytochemistry has not been described previously. The phytochemistry of three species in this genus has been investigated and eight compounds, including three bufadienolides (compounds 1, 4, and 5), a norlignan (2), and four homoisoflavonoids (compounds 3 and 6-8) have been isolated and identified. Compounds 1-3 and 6-8 have not been described previously. The COX-2 inhibitory activity of compound 6 and compound 7 acetate (compound 7A) were investigated on isolated colorectal cancer cells. Compounds 6 and 7A inhibited COX-2 by 10% and 8%, respectively, at a concentration of 12.5 M compared to 12% for 1 mM aspirin (the positive control).
HRESIMS indicated a molecular formula of C 30 Hz) and 6.29 (H-23, dd, J = 9.7 Hz, 0.9 Hz). The H-21 and H-22 resonances showed correlations in the HMBC spectrum with a methine carbon resonance (δ C 52.2) that could be assigned to C-17. The HMBC spectrum showed correlations between the C-17 resonance and the only methyl group proton resonance, which was assigned as CH 3 -18 (δ H 0.68, s) and between the corresponding H-17 resonance (δ H 2.56, dd, J = 6.4 Hz, 9.5 Hz) and an oxygenated carbon resonance (δ C 85.6), which was assigned as C-14, and hence a hydroxy group was placed at this position. Thus, the usual CH 3 20 The glycoside derivative of 19-oxobufalin has not been reported previously.
Compound 2 is a new norlignan, with a previously unreported skeleton, isolated as its diacetyl derivative, compound 2A, after acetylation of a complex mixture to aid separation. The two H-9', H-7 and two H-8 resonances showed a correlation in the HMBC spectrum with a lactone carbonyl resonance at δ C 176.9, which was assigned as C-9.
The NOESY spectrum was used to assign the relative configuration of compound 2A. ECD studies were used to determine the absolute stereostructure of compound 2A. A conformational analysis using molecular mechanics force fields (MMFF) on SPARTAN08 software was undertaken for X and Y and the conformers with energy of less than 2 kcal/mol were subjected to TDDFT calculations employing B3LYP, 6-31G basis in Gaussian09 software. The calculated ECD curves were compared to the experimental ECD for compound 2A (Figure 2 ). The experimental ECD curve gave a positive Cotton effect at 267 nm (+1.6) and negative Cotton effects at 219 nm (-3.9) and 304 (- 22 so an ECD study was undertaken. The measured ECD spectrum showed Cotton effects of +1.54 at 290 nm and -0.9 at 240 nm for the unusual S-configuration. 23 In all homoisoflavonoids reported from the Hyacinthoideae subfamily, where the configuration at C-3 has been determined, it has been reported as R, with the exception of only three homoisoflavonoids isolated by Nishida et al. 24 from Barnardia japonica (Thunb.) Wijnands (investigated as Scilla scilloides (Lind.) Druce), which also showed the S-configuration, as determined by an ECD study. The unusual 3S-configuration has been reported once from the Urginiodeae subfamily, from Urginea depressa. 25 The isolation of compound 3 was facilitated by acetylation yielding two products, the 3'-acetate, (3A) and the 5,7-diacetate, Hz) was found at C-3 as opposed to a benzylidene group. The proton spectrum indicated the presence of two methoxy groups ( H 3.88 and  H 3.94). As in compounds 6 and 7, a 3',4'-substitution pattern was present in ring B, and a NOESY correlation between one of the methoxy groups and the H-5' resonance was used to place one of these at C-4'. The HMBC spectrum showed correlations between the C-4' resonance and the H-2' ( H 6.65), H-6'
( H 6.60) and H-5' ( H 6.79) resonances. A hydroxy group was placed at the remaining C-3' position on ring B. The NOESY spectrum also showed a correlation between a hydroxy group proton resonance at  H 8.90 and the C-5 hydroxy group proton resonance ( H 12.23), so a further hydroxy group was placed at C-6. The C-7 ( C 137.11resonance showed a correlation with the methoxy group three-proton singlet and the H-8 resonance in the HMBC spectrum. The ECD spectrum indicated a positive Cotton effect at 291 nm and as such the absolute configuration at C-3 was assigned as S (H-). 23 This configuration appears to be characteristic of the Rhodocodon homoisoflavonoids, although not common among homoisoflavonoids.
Compounds 6 and 7A and the crude plant extracts were screened for COX-2 expression, and PGE-2 release. To gain some idea of their therapeutic potential, the effects of compounds 6 and 7A on COX-2 expression and activity (determined based on PGE-2 release from HCA-7 cells) was compared to that of aspirin, which has been demonstrated to reduce the incidence and also the mortality of colorectal cancer, 33, 34 and when at the concentration used in the present study (1 mM) has been shown to inhibit induced COX-2 expression in CRC cells in vitro. 35 The western blotting results for the COX-2 expression experiments,
showed that both compounds 6 and 7A slightly inhibited COX-2 expression compared to the untreated control by 10% (12 M) and 8% (12 M), respectively (Figures S1 and S2, Supporting Information), whereas aspirin (1 mM) inhibited COX-2 expression by 12%. The DMSO control had no effect on expression ( Figure S3 , Supporting Information). The effect of whole plant extracts of plant material was investigated but for all concentrations tested (20 g/mL -9 mg/mL) all cells were killed after a 48 h period of incubation so it was not possible to determine the effects of these extracts on COX-2 expression.
In tests for PGE-2 release from HCA-7 cells, some inhibition was seen (11% and 20% for compounds 7A and 6, respectively, at 12 M), the effect of compound 6 being statistically significant (Table 5 ). These results suggest that these compounds have a greater effect on COX-2 activity than expression. Aspirin (1 mM) inhibited PGE-2 release by 19% but DMSO showed no inhibition compared to the control (Table 5 ). For the reasons given above, it was not possible to determine the effect of the whole plant extracts on PGE-2 release.
It is well established that some phenolic compounds, and plants rich in them, may possess anti-inflammatory activity via their inhibitory effect on a wide range of key inflammatory mediators, including COX-2. [36] [37] [38] [39] [40] [41] The effect of the homoisflavonoids 6 and 7A
on COX-2 expression and activity is consistent with these findings and those of Waller et al. 5 who reported that homoisoflavones from Ledebouria socialis and L. ovatifolia inhibited COX-2 activity based on an in vitro assay. However, the findings of the present study suggest that in terms of their therapeutic potential, with regard to CRC cells, the target may be COX-2 activity rather than its expression. When compared to the effect of aspirin (1 mM) on COX-2 activity (as indicated by PGE-2 release) the data suggest that at the concentrations used, compounds 6 and 7A at 12.5 M were as effective at inhibiting COX-2 activity as aspirin at a concentration of 1 mM. It is possible that at higher concentrations, especially for compound 6, which inhibited COX-2 activity by 20%, compared to 19% for aspirin, the inhibitory effect would have been greater. However, it must be borne in mind that aspirin is not a selective COX-2 inhibitor 16 and so for future studies a comparison of these and other homoisoflavanoids against a more appropriate inhibitor such as the NSAID celecoxib, which is considered by some to be clinically relevant in the treatment of colorectal cancer, is required. 16, 42 The effect of these compounds on CRC cells in vitro should not be limited to COX-2, as the development and progression of colorectal cancer occurs via several molecular mechanisms, [43] [44] [45] [46] and so future studies will be needed to further investigate and characterize the effect of these compounds on the growth of HCA-7, and other types of colorectal cancer cells to gain greater insight into their therapeutic potential.
EXPERIMENTAL
General Experimental Procedures. Optical rotations were recorded in CHCl 3 on a JASCO P-1020 polarimeter (University of Surrey), the UV spectra were recorded using a Biochrom libraS60 in MeOH or acetonitrile in a 1 cm cell (University of Surrey), and the ECD spectra were recorded using a Chirascan spectropolarimeter at room temperature in a 1 cm cell in Acetylation Procedure. Compounds or fractions to be acetylated were dissolved in pyridine (2 mL) in a round-bottomed flask, acetic anhydride (2 mL) was added, and the reaction was left to stand overnight. Methanol (10 mL) was added to the reaction mixture to remove unreacted acetic anhydride. Toluene (4 x 10 mL) was added in order to remove the pyridine, and was removed using a rotary evaporator. Thereafter, methanol (5 x 10 mL) was added and evaporated off to remove the remaining toluene. The fractions were subjected to column chromatography over silica gel (Merck 9385, 4:1 ether-hexane) to yield 3A then preparative TLC was used to yield 2A and 3B (Scheme S1, Supplementary Information 
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Yellow gum; UV (CH 3 CN)  max (log ) 365 (4.09) nm; IR (NaCl) fetal bovine serum (FBS) (Sigma-Aldrich, UK F7524) and incubated at 37 C and 5% CO 2 .
After 48 h, when cells were almost 80% confluent, each whole plant extract (in % DMSO) (20 g/mL -9 mg/mL) or homoisoflavonoid compounds 6 and 7A (12.5 M) in 100% DMSO was added and left for another 48 h. Controls were also set up and were "no treatment" (cell culture medium only), a DMSO control (HCA-7 cells in 0.3% DMSO) and a positive control (1 mM aspirin, (Sigma-Aldrich, UK A5376-100 g). Compounds 6 and 7A were selected for this part of the investigation as the amounts in DMSO were known. After the second 48 h incubation, cells were lysed using LDS NuPAGE lysis buffer (Fisher, UK 10718414) and the western blotting was performed using equal amounts of sample (lysed cells) based on protein content, (30 g).
PGE-2 is a product of COX-2 and thus PGE-2 release by cells expressing COX-2 is
commonly used as a marker of COX-2 activity, 16 thus the effect of compounds 6 and 7A on PGE-2 release by HCA-7 cells was investigated. HCA-7 cells were seeded and incubated as described above. After the second 48 h period, the cell culture medium was collected and stored at -20 C. For the PGE-2 assay, the samples were defrosted, centrifuged at 1000 rpm for 4 min, and then assayed using a PGE-2 ELISA kit, according to the manufacturer's instructions (RND Systems, UK KGE004B). This assay is based on the forward sequential Figure S1 . Effect of compounds 6 and 7A on COX-2 expression in HCA-7 cells n = at least three separate experiments. 
